Zydus Lifesciences and Torrent Pharmaceuticals have entered into a strategic licensing and supply agreement to co-market Semaglutide injection in India, marking a significant move in the fast-growing metabolic disorders segment. Under the agreement, Zydus will manufacture and supply the drug, while Torrent Pharma will hold semi-exclusive rights to co-market it under its own brand, Sembolic, […]